Black Robe Capital LLC
CIK: 0001977553
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INTI
Inhibitor Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About Black Robe Capital LLC
Black Robe Capital LLC (SEC CIK 0001977553) files insider reports with the SEC as 10% Owner of Inhibitor Therapeutics, Inc. (INTI).
Signal8 holds 1 ownership filing by Black Robe Capital LLC, a Form 4, filed on Aug 4, 2026. Those filings report 1 transaction, the latest on Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Black Robe Capital LLC's filings is in TAMPA, FL.
Recent filings by Black Robe Capital LLC
- Jul 1, 2026: Gift of INTI shares (Form 4, code G).
Other insiders filing for Inhibitor Therapeutics, Inc. (INTI)
- OSMAN RONALD E, Director
- Yanez Michelle, Director
- SEARS SAMUEL P JR, Director
- ODONNELL FRANCIS E JR, Chief Executive Officer
- Jerman Michael Allen, Director
- Vasisht Niraj, Director